SUN PHARMACEUTICAL INDUSTRIES
Back to Income Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹11,479 Cr | ₹10,929 Cr | ₹9,576 Cr | ₹8,474 Cr | ₹3,273 Cr |
What is the latest Consolidated Net Profit of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹11,479 Cr |
| Mar2025 | ₹10,929 Cr |
| Mar2024 | ₹9,576 Cr |
| Mar2023 | ₹8,474 Cr |
| Mar2022 | ₹3,273 Cr |
How is Consolidated Net Profit of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹11,479 Cr | 5.04 | |
| Mar2025 | ₹10,929 Cr | 14.12 | |
| Mar2024 | ₹9,576 Cr | 13.01 | |
| Mar2023 | ₹8,474 Cr | 158.91 | |
| Mar2022 | ₹3,273 Cr | - | |
Compare Consolidated Net Profit of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,689.6 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| MANKIND PHARMA | ₹98,598.7 Cr | 0.5% | -7.4% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 0.5% |
-4% |
15.7% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses